Research Topics
| Susan B BroglySummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practiceSusan Brogly
Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Mass 02115 6017, USA
JAMA 293:2213-20. 2005..However, the integration of novel ART into the clinical care of pediatric HIV infection has not been examined...
Reproductive health of adolescent girls perinatally infected with HIVSusan B Brogly
Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Mass 02115 6017, USA
Am J Public Health 97:1047-52. 2007..We sought to describe the reproductive health of adolescent girls perinatally infected with HIV...- Participation of HIV-infected pregnant women in research in the United StatesSusan Brogly
Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA 02115 6017, USA
AIDS Res Hum Retroviruses 23:51-3. 2007..This high rate of nonenrollment can bias study results and generate findings that are applicable only to particular groups of women. Efforts should be taken to design protocols that facilitate enrollment of HIV-infected pregnant women... - Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretroviralsDavid W Ouyang
Division of Maternal Fetal Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
AIDS 24:109-14. 2010..To estimate whether HIV-infected pregnant women were at an increased risk of hepatotoxicity when taking nevirapine (NVP)-containing regimens compared with HIV-infected pregnant women taking antiretroviral therapy (ART) not containing NVP... - Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219CSusan B Brogly
Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA, USA
Pediatr Infect Dis J 29:721-7. 2010..Some studies have detected associations between in utero antiretroviral therapy (ARV) exposure and birth defects but evidence is inconclusive... - In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected childrenSusan B Brogly
Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts 02115, USA
AIDS 21:929-38. 2007..There is equivocal evidence of in utero nucleoside reverse transcriptase inhibitor (NRTI) exposure and the occurrence of mitochondrial dysfunction (MD) in HIV-uninfected children born of HIV-infected women... - Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapyNathalie Ylitalo
Department of Epidemiology and Biostatistics and Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Mass 02155, USA
Arch Pediatr Adolesc Med 160:778-87. 2006..To examine the relationship between the use of highly active antiretroviral treatment (HAART) and the occurrence of opportunistic illnesses (OIs) among children perinatally infected with human immunodeficiency virus... - Short communication: transplacental nucleoside analogue exposure and mitochondrial parameters in HIV-uninfected childrenSusan B Brogly
Center for Biostatistics in AIDS Research, Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA
AIDS Res Hum Retroviruses 27:777-83. 2011..No deletions were found. The long-term significance of these small but potentially important alterations should continue to be studied as these children enter adolescence and adulthood... - Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancyKunjal Patel
Department of Epidemiology, Harvard School of Public Health, Boston Massachusetts 02115, USA
J Infect Dis 201:1035-44. 2010..Conflicting results have been reported among studies of protease inhibitor (PI) use during pregnancy and preterm birth. Uncontrolled confounding by indication may explain some of the differences among studies... - Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infantsPaige L Williams
Department of Biostatistics, Harvard School of Public Health, 665 Huntington Ave, Building I, 415, Boston, MA 02115 6017, USA
Pediatrics 125:e250-60. 2010..Although ARV use has significantly reduced mother-to-child transmission to <2% in the United States, it remains crucial to monitor uninfected infants and children for adverse consequences of in utero ARV exposure... - Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysisKatherine Tassiopoulos
Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
AIDS Behav 14:1269-78. 2010..Illicit substance use was low and substantially less than that reported in earlier studies of HIV-infected women, but alcohol and tobacco exposure was prevalent... - Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter studyRebecca B Perkins
Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
J Womens Health (Larchmt) 21:813-20. 2012..Low rates of human papillomavirus (HPV) vaccination in low-income, minority adolescents may exacerbate racial disparities in cervical cancer incidence... - Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilizationJulie Bruneau
Departments of Psychiatry and Family Medicine, University of Montreal, Canada
Addiction 99:727-37. 2004.... - HIV-positive notification and behavior changes in Montreal injection drug usersSusan B Brogly
Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada
AIDS Educ Prev 14:17-28. 2002..4, 48.9), and sex work, ND = 31.8% (95% CI = 12.4, 51.3), and fewer began new relations, ND = -38.2% (95% CI = -52.6, -23.9). The medical community and NEPs have an important role in providing support for newly diagnosed IDUs...